JMB-HEADER RAS-JOURNALS EIMB Pleiades Publishing

RUS

             

ENG

YearIMPACT-FACTOR
2022  1,200
2021  1,540
2020  1,374
2019  1,023
2018  0,932
2017  0,977
2016  0,799
2015  0,662
2014  0,740
2013  0,739
2012  0,637
2011  0,658
2010  0,654
2009  0,570
2008  0,849
2007  0,805
2006  0,330
2005  0,435
2004  0,623
2003  0,567
2002  0,641
2001  0,490
2000  0,477
1999  0,762
1998  0,785
1997  0,507
1996  0,518
1995  0,502
Vol 52(2018) N 5 p. 648-659; DOI 10.1134/S0026893318050060 Full Text

A.Yu. Egorshina1, A.V. Zamaraev1, I.N. Lavrik1,2, B.D. Zhivotovsky1,3*, G.S. Kopeina1**

Caspase-2 as an Oncosupressor and Metabolism Regulator: What Life Will Bring over the Long Run?

1Faculty of Basic Medicine, Moscow State University, Moscow, 119192 Russia
2Medical Faculty, Otto von Guericke University, Magdeburg, 39120 Germany
3Karolinska Institutet, Stockholm, 17177 Sweden

*Boris.Zhivotovsky@ki.se
**lirroster@gmail.com
Received - 2018-02-20; Accepted - 2018-03-29

Programmed cell death is governed by a set of gene networks, which define a variety of distinct molecular mechanisms essential for the maintenance of multicellular organisms. The most studied modality of programmed cell death is known as apoptosis. Caspase-2, as a member of the family of the cysteine-dependent protease, demonstrates both proapoptotic and tumor suppressive functions. This protease plays an essential role in the maintenance of genomic stability and induces apoptotic cell death in response to geno-toxic stress. Here we discuss the molecular mechanisms of caspase-2 regulation and its physiological role as a tumor suppressor and metabolic regulator.

apoptosis, caspase-2, tumor suppressor, metabolism



JMB-FOOTER RAS-JOURNALS